These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8796263)

  • 21. The Hageman factor-dependent system in the vascular permeability reaction.
    Yamamoto T; Kozono K; Kambara T; Cochrane CG
    Biochim Biophys Acta; 1988 Aug; 966(2):196-206. PubMed ID: 3401504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification of guinea-pig plasma prekallikrein. Activation by prekallikrein activator derived from guinea-pig skin.
    Yamamoto T; Kozono K; Okamoto T; Kato H; Kambara T
    Biochim Biophys Acta; 1980 Aug; 614(2):511-25. PubMed ID: 6967737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triggering of the vascular permeability reaction by activation of the Hageman factor-prekallikrein system by house dust mite proteinase.
    Maruo K; Akaike T; Matsumura Y; Kohmoto S; Inada Y; Ono T; Arao T; Maeda H
    Biochim Biophys Acta; 1991 May; 1074(1):62-8. PubMed ID: 2043681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of vascular permeability upon serratial infection: activation of Hageman factor--kallikrein--kinin cascade.
    Matsumoto K; Yamamoto T; Kamata R; Maeda H
    Adv Exp Med Biol; 1986; 198 Pt B():71-8. PubMed ID: 2880483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of various infusion media and solutions on the kallikrein-kinin system of human plasma].
    Dotsenko VL; Morozova NA; Iarovaia GA
    Vopr Med Khim; 1985; 31(4):116-21. PubMed ID: 3931350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of Hageman factor (HG, factor XII) and plasma prekallikrein (Fletcher factor) by radioimmunoassays.
    Saito H
    Adv Exp Med Biol; 1979; 120A():165-72. PubMed ID: 573961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation mechanism of human Hageman factor-plasma kallikrein-kinin system by Vibrio vulnificus metalloprotease.
    Miyoshi S; Shinoda S
    FEBS Lett; 1992 Aug; 308(3):315-9. PubMed ID: 1380471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
    Griffin JH; Cochrane CG
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor).
    Kisiel W; Fujikawa K; Davie EW
    Biochemistry; 1977 Sep; 16(19):4189-94. PubMed ID: 901769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of bovine factor VII by hageman factor fragments.
    Radcliffe R; Bagdasarian A; Colman R; Nemerson Y
    Blood; 1977 Oct; 50(4):611-7. PubMed ID: 561632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaphylactic release of a prekallikrein activator from human lung in vitro.
    Meier HL; Kaplan AP; Lichtenstein LM; Revak S; Cochrane CG; Newball HH
    J Clin Invest; 1983 Aug; 72(2):574-81. PubMed ID: 6192147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
    Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced specificity of immunoblotting using radiolabeled antigen overlay: studies of blood coagulation factor XII and prekallikrein in plasma.
    Lämmle B; Berrettini M; Griffin JH
    Anal Biochem; 1986 Jul; 156(1):118-25. PubMed ID: 3638135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hageman factor dependent kinin generation system in guinea pig skin: extravascular localization of the components, and prolonged vascular reaction in inhibitor-depleted animal of this system.
    Yamamoto T; Ishimatsu T; Kambara T
    Adv Exp Med Biol; 1989; 247A():447-52. PubMed ID: 2603811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of prekallikrein activation in human plasma by components of bovine plasma.
    Weerasinghe KM; Kirby EP
    Inflammation; 1992 Oct; 16(5):497-507. PubMed ID: 1428124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prekallikrein activation in human, bovine, and rabbit plasmas: presence of an inhibitor in bovine plasma.
    Weerasinghe KM
    Inflammation; 1992 Jun; 16(3):205-13. PubMed ID: 1500097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent evolutionary divergence of plasma prekallikrein and factor XI.
    Veloso D; Shilling J; Shine J; Fitch WM; Colman RW
    Thromb Res; 1986 Jul; 43(2):153-60. PubMed ID: 3638032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.